Nolato AB Series B | Income Statement

Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,522
4,234
4,726
4,447
6,720
8,102
Cost of Goods Sold (COGS) incl. D&A
3,678
3,313
3,574
3,357
5,165
6,243
Gross Income
844
921
1,152
1,090
1,555
1,859
SG&A Expense
444
470
609
661
798
938
EBIT
400
451
543
429
757
921
Unusual Expense
14
6
-
4
-
20
Non Operating Income/Expense
7
23
11
12
16
7
Interest Expense
7
10
4
2
13
24
Pretax Income
403
462
555
438
731
921
Income Tax
89
98
135
102
159
199
Consolidated Net Income
314
364
420
336
572
722
Net Income
314
364
420
336
572
722
Net Income After Extraordinaries
314
364
420
336
572
722
Net Income Available to Common
314
364
420
336
572
722
EPS (Basic)
11.94
13.84
15.97
12.77
21.74
27.44
Basic Shares Outstanding
26
26
26
26
26
26
EPS (Diluted)
11.94
13.84
15.97
12.77
21.74
27.37
Diluted Shares Outstanding
26
26
26
26
26
26
EBITDA
557
616
724
622
988
1,169
Non-Operating Interest Income
3
4
5
3
3
11

About Nolato AB

View Profile
Address
Nolatovägen
Torekov SN 269 04
Sweden
Employees -
Website http://www.nolato.com
Updated 07/08/2019
Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. It operates through the following segments: Medical Solutions, Integrated Solutions, and Industrial Solutions. The Medical Solutions segment develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements.